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Introductory note 
Accuracy is the keyword when it comes to radiotherapy. More advanced treatments 
usually take more time, so immobilization is mandatory. However, immobilization does 
not resolve the intrafraction motion problem, whether it is caused by natural processes 
such as breathing and heart beating or patient intentional movement. 
This question led to the development of the Calypso® 4D Localization System. This is 
a system that monitors internal movement when treating allowing to interrupt and to 
correct any shift that occurs during treatment (intrafraction motion). That way it is 
possible to detect when the patient moves and also to account for internal movement. 
This technology was recently acquired and installed in Champalimaud Clinical Center.  
Considering that I am a radiation therapist in this center where the purpose is to ensure 
good quality of administered treatments, I could not do but to direct this work towards 
the field in which I dwell daily. It is advisable to study the effect of any new equipment 
in treatment delivery and that gives the opportunity to acquire and to explore local data. 
In the first part of this work, a review on state-of-the-art literature is provided (previously 
submitted in December 2013 and accepted in May 2014), as to allow for a fully 
comprehension of the subject discussed here: how Calypso® system works, its 
advantages when compared to other monitoring systems available and how it is being 
used around the world.  
After knowing how Calypso® works, one question is inevitable. In order to monitor the 
patient continuously an array is positioned above the patient during the treatment and 
the treatment planning system does not account for that. How much dose does the 
array attenuate? The second part of this work assesses this subject. A study was 
performed by measuring the transmitted radiation of several beams (with beam energy, 
field size and gantry angle variation) with and without the array in the beam path and 
the attenuation was calculated and analyzed (previously submitted in May).  
Finally, the third part of this work studies radiation attenuation in treatment tabletops. It 
was noted when Calypso® system was being installed that changing the treatment 
table was part of the installation process. For the system to work properly no electric 
conductive materials are allowed in the array’s volume detection, as the system 
functions by electromagnetic detection. Carbon fiber is an electric conductive material 
so the Varian Exact IGRT tabletop was replaced by a table with the two exchangeable 
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inserts kVueTM Universal Tip Insert (carbon fibre) and kVueTM Calypso ® Varian Insert 
(kevlar). 
A study was performed in order to determine if there was any loss in treatment 
administration quality due to the radiation attenuated in the treatment tabletop. 
Radiation measurements were performed without tabletop and also with each of the 
three tabletops (with beam energy, field size and gantry angle variation). Attenuation 
was calculated for the three tabletops. It was assessed if new tabletops attenuated 
more or less radiation than the original one, and it was considered if it was adequate 
not to switch between kVueTM Calypso® Varian and kVueTM Universal Tip tabletops 
according to the use of calypso system or not, respectively. 
It is noteworthy that the Master Commission authorized the presentation of this work as 
three scientific articles written in English, with the purpose of future publication in 
international, peer-reviewed journals. In order to do so it respects some criteria related 
to this objective. 
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Abstract 
Purpose: Calypso® four-dimensional localization system is a system based on 
electromagnetic transponders detection enabling precise three-dimensional localization 
and continuous tracking of tumor target. This review intended to provide information in 
order to (1) show how Calypso 4D Localization System® works, (2) to present 
advantages and disadvantages of this system, (3) to gather information from several 
clinical studies and, finally, (4) to refer Calypso System as a tool in Dynamic Multileaf 
Collimator studies for target motion compensation. 
Methods: A structured search was carried out on b-On platform. The key words used in 
this research were “Calypso”, “Transponder”, “Electromagnetic Localization”, 
“Electromagnetic Tracking”, Target Localization”, “Intrafraction Motion” and “DMLC”.  
Review: Treatment the implanted transponders are excited by an electromagnetic field 
and resonate back. These frequencies are detected and Calypso software calculates 
the position of the transponders. If the movement detected is larger than the limits 
previously defined, irradiation can be stopped. The system has been proven to be 
submillimeter accurate.  
Discussion: Calypso® system has been presented as an accurate tool in prostate 
radiotherapy treatments. The application of this system to other clinical sites is being 
developed. 
Conclusion: The Calypso® system allows real-time localization and monitoring of the 
target, without additional ionizing radiation administration. It has been a very useful tool 
in prostate cancer treatment.  
Key words: Calypso, DMLC, Beacon ® transponders, Prostate, Lung. 
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Introduction 
The main goal in radiation therapy is to deliver a prescribed dose to a target volume 
while minimizing toxicity to adjacent healthy tissues. One potential way to decrease 
radiation related toxicity would be to spare more normal tissues (1-5). The latest 
equipment development now allows us to use more precise and conformal techniques 
when delivering radiation, such as IMRT (Intensity Modulated Radiotherapy) and IMAT 
(Intensity Modulated Arc Therapy) techniques. The introduction of these techniques 
demands for precise target immobilization and localization so there is minimal 
movement during treatment (6). 
New imaging modalities have improved localization and setup accuracy. The possibility 
to acquire a ConeBeamCT (CBCT) before treatment allows professionals to make 
adjustments according to the target and surrounding organs position, instead of making 
adjustments according to boney position (MV planar images) (7-16). CBCT images can 
be acquired before and/or after treatment delivery or even between beams. 
Nevertheless, that does not account for movement that may occur during treatment 
and organ motion is a major obstacle to reducing margins without compromising dose 
to the target volume (17). Camille Noel et al. studied this pre- and post-treatment CBCT 
acquisition as a way of predicting intrafraction movement in prostate patients. The 
conclusion of this study indicated that this imaging acquisition is not a good predictor of 
intrafraction prostate motion (18). 
In order to consider internal movement, various methods have been used for real-time 
tracking. Methods as fluoroscopy and mega-voltage imaging (associated or not with 
gold fiducials) have the disadvantage of increasing the radiation delivered to the 
patient. On the other hand infrared tracking of external markers consider external 
movement as directly related to internal movement, but this correlation has been 
proven to be imperfect (7-16; 19-21). 
The Calypso 4D Localization System (Calypso Medical, Seatle, WA) is a wireless 
electromagnetic localization system which aims to target tumors accurately before and 
during treatment delivery (22).  
This review provides information  in order to (1) show how Calypso 4D Localization 
System works, (2) to present advantages and disadvantages of this system, (3) to 
gather information from several clinical studies and, finally, (4) to refer Calypso System 
as a tool in Dynamic MLC (DMLC) studies for target motion compensation. 
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Materials and methods 
The review was based on literature searched on B-On Platform. The key words used in 
this research were “Calypso”, “Transponder”, “Electromagnetic Localization”, 
“Electromagnetic Tracking”, Target Localization”, “Intrafraction Motion” and “DMLC”. 
The search provided several articles since January 2005. After reading and analyzing 
the B-On search, a selection of references mentioned in some of these articles was 
made and also analyzed and included in this review. 
 
The Calypso 4D Localization System 
This system has five components: Beacon transponders (specially created for Calypso 
system), the console, the array, the optical localization subsystem and the monitoring 
station (23). 
Each transponder consists of a sealed glass capsule containing a miniature electronic 
circuit. Transponders are 8,7 mm length and 1,85 mm in diameter and are biologically 
inert (6, 23, 24). Typically, three Beacons are implanted in the patient. Only two 
transponders are necessary for the system to calculate translational movements. 
However, to have information about rotations a minimum of three transponders is 
needed (23-25). The transponders resonate when excited with the electromagnetic 
field generated by the array. Each transponder has a unique frequency response. The 
transponders are also color coded with their intended position, which allows them to be 
distinguished individually. Sensors in the array measure the magnetic field strength 
from each transponder and the software can calculate the location of each transponder 
(22, 23, 26, 27). 
The console is inside the treatment room. It is a movable unit that gathers a power 
supply, a computer with the software that calculates transponders location, cables, and 
the array (23). 
The array contains source coils, sensors and infrared targets. The source coils 
generate the electromagnetic fields that excite the transponders. The sensors of the 
array receive the resonant signals of each transponder and the infrared targets are 
detected by infrared cameras (22, 23). The array is positioned above the patient, with 
minimum beam attenuation (28). 
Three infrared cameras are mounted in the treatment room so that the array position is 
continuously monitored. The array location yields the position of the center of the 
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target, with respect to the machine isocenter. This means that the system calculates 
the table translation movements that are necessary to have the Beacons positioned at 
the treatment unit according to the planning CT scan. The positional information is 
simultaneously displayed and updated in the console as it is in the control area (23, 24, 
27, 29) (Figure 1).  
 
Figure 1. Tracking station display: in this example the patient is positioned in (0, 
0, 0) Calypso® coordinates (black line) and during the monitoring period 
beacons’ movements are within acceptable limits (grey zone) whenever the 
graph is blue, and outside acceptable limits (black zone) whenever the graph is 
yellow; the actual shift value for the three coordinates is on the screen left side 
(reproduced by kind permission of Calypso from Calypso System User’s 
Manual). 
 
Radiation therapists are in the control area monitoring the movement of the target 
during the treatment delivery through the observation of the data that is being displayed 
on the monitoring station. Visual and audio alerts warn therapists that the target has 
exceeded the limits established (23, 30).  
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Advantages (22, 31-35) 
• No additional ionizing radiation is delivered to the patient;  
• The target is monitored continuously; 
• Real-time information is provided so that action may be taken to limit the 
influence of intrafraction motion (33); 
• Three dimensional target tracking; 
• Not dependent on target size: the system relates to a virtual point about which 
the physician defined radiation volume is actually delivered; 
• The transponders are implanted directly into the target volume; 
• The implantation procedures are generally uneventful and well tolerated by the 
patients (23); 
• Compact; 
• Biocompatible; 
• Transponders are compatible with Computed Tomography (CT) imaging and, in 
some cases, megavoltage imaging; 
• Connection between Calypso System and Linear Accelerator: the irradiation 
may stop automatically when the detected movement is superior to the 
threshold previously defined (available only for Varian Edge Platform); 
 
Disadvantages (23, 25, 29, 30, 36, 37) 
• Extra imaging may be needed to assess fully the Planning Target Volume 
(PTV) and the organs at risk (OARs) – e. g. the system may confirm that the 
prostate is in the right position, but no information is given regarding the size of 
the bladder, an image is required to evaluate that OAR; 
• Need for implantation; 
• Calypso® manual considers a localization volume under the array of 14 x 14 x 
27 cm3 space in lateral, longitudinal and vertical directions (32) therefore the 
Beacons should be placed so that they are inside this volume during treatment; 
• Implanted Beacons may result in a problem when MRI follow-up exams are 
performed: the RF transmitters in the Beacons create huge image artifacts (37); 
• Patients with pacemakers should be handled with care; 
• After implantation, Beacons stay inside the patient and cannot be re-used; 
• Patients with certain prostheses may not be suitable candidates for this system; 
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Quality Assurance 
The accuracy of the system has been verified to sub millimeter accuracy, in several 
laboratory and clinical studies. 
Balter et al. report the results for several tests focused on the accuracy of transponder 
localization relative to the array. First a single transponder was positioned at locations 
up to 8 cm in the X and Y planes from the center position, at Z distances of 8 and 27 
cm from the array. A continuous readout of the transponder positions was recorded at 
these positions for periods up to 20 min. At 8 cm distance from the array the offset after 
15 min the readouts were +0,03, +0,05 and -0,09 mm for the X, Y and Z directions 
respectively. At 27 cm distance from the array after 15 min the readouts were +0,19, 
+0,22 and -0,2 mm for the same directions, respectively (31).  
The experiment was repeated with the beacon in 0,9 % saline solution (concentration 
that simulates a conductivity environment compared to twice that of human tissue). At 
27 cm distance from the array and 8 cm away from the center the readouts after 20s 
were +0,29, +0,43 and -0,33 mm for the same directions, respectively (31).  
After concluding that the system correctly detects one beacon, the experience was 
repeated at 8 and 27 cm offset from the array, this time with a set of three beacons: at 
Z distance of 8 cm the offset was +0,17, +0,03 and +0,05 mm and at Z distance of 27 
cm the offset was +0,16, +0,18 and +0,12 mm for X, Y and Z, respectively, for both 
measurements (31). 
Ogunleye et al. compared Calypso® system with kV planar imaging for localization of 
markers. In this case Beacons were the markers to be localized as they are detected 
by Calypso® system (magnetic resonance) and they are also detected in x-ray image 
(radio opaque) (38). 
A stationary phantom was not aligned in the isocenter. The measured offset of the 
target isocenter from the correct position as indicated by the Calypso system should be 
the exact opposite of the OBI shift required to move the target isocenter to the correct 
position. The values were compared for 30 different phantom positions. The difference 
between the two systems was 0,4 (δ=0,4); 0,2 (δ=0,3) and 0,4 (δ=0,3) mm in the X, Y 
and Z directions, respectively (38). The process was repeated with 259 prostate 
treatment fractions. The difference between the two systems was 0,7 (δ=0,5); 1,1 
(δ=0,9) and 1,2 (δ=0,9) mm in the X, Y and Z directions, respectively (38). 
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Action Protocol for Treatment Intervention 
The above mentioned target positioning limits are inserted into the Calypso software 
according to an Action Protocol for Treatment Intervention. Several protocols have 
been reported. 
Shinohara et al. studied five locally advanced pancreatic cancer patients with a 3mm-
action protocol. The therapists were to interrupt radiation delivery every time 
intrafractional motion was greater than 3 mm (17). In a prostate study by Smith et al. 
the same action level was established (40). 
Also in a prostate study by Su et al. a 5 mm shift as threshold was used. A re-
localization was to be performed only if the Beacon centroid drifted more than 5 mm for 
25 seconds continuously (41). 
One of the prone position studies was reported by Shah et al.  In this study, therapists 
were instructed to observe the prostate gland position and intervene when the motion 
was larger than 3 mm. However, if the motion was transient as peristaltic movement, 
even if exceeding 3 mm, the therapists should not act. Also, intervention should be 
between beams (38). 
 
Clinical Applications  
The Calypso 4D Localization System has been approved for marketing by FDA for 
target organ positioning and monitoring during delivery of radiation therapy in prostate 
cancer patients  (23). Most recently, CE Mark approved Calypso Anchored Beacons to 
be used in lung treatments as well. Several studies considering future clinical 
applications have been performed. 
Prostate 
The implantation procedures are generally uneventful and well tolerated by patients. 
Quigley et al. refer that fifty two percent of patients in their study (22/42) reported 
symptoms after the implantation procedure. Those symptoms were not revealed, but 
it was referred that those were usual symptoms after similar procedures as 
implantation of gold fiducials (23, 25, 34, 35).  
It is to be mentioned that, after the implantation of fiducials, the prostate usually 
swells (inflammatory response). There may be a change in fiducials position when 
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prostate swells and also when it returns back to its natural position. Litzenberg et al. 
reported that it is safe to acquire a planning CT scan 4 days after implantation, as 
any swelling appears to have resolved by then (6). 
Calypso System has been a very important tool in the most recent studies of 
intrafraction prostate motion (2, 42, 44, 45). These movements are caused not only 
by repeating processes such as breathing, but also because of random processes 
like gradual rectal distention, peristaltic motion and bladder volume. This means 
prostate movement is random, sporadic and patient specific, which makes the 
prediction of the prostate motion difficult. 
As above mentioned Calypso® manual considers a localization volume under the 
array of 14 x 14 x 27 cm3 which means that patients with protuberant abdomen may 
not be a suitable candidate for this system. When considering the localization 
volume of the system, the recommendation is that the maximum distance between 
the array and the beacons should be less than 27 cm. On the other hand Bittner et 
al. (30) and Quigley et al. (23) assumed that this distance should not be more than 
23 cm in their studies’ patient selection. The latter led to several studies in order to 
present the prone position as an alternative position to treat these patients with 
Calypso accurately (36, 38, 43). Shah et al. refer that prostate displacements larger 
than 3 and 5 mm were higher in the prone position by a factor of three in 
comparison to the supine position. Displacements larger than 10 mm occurred as 
often in the prone as in the supine position.  
Lung 
Implantation of transponders in lungs has some risks. The current design of the 
transponders was not the most appropriate for lung implantation: although they 
show good to moderate shot-term fixation rates, long-term fixation rates are low 
(46). Percutaneous implantation in the lung led to a significant rate of pneumothorax 
(47). However, bronchoscopic implantation has been safer (48, 49). 
In the meantime, Calypso Medical has developed a new transponder design with a 
stabilization feature: Calypso Anchored Beacon. This improved Beacon is a regular 
Beacon with a 5-legged nitinol stability feature. These five legs are to anchor the 
transponder in a small diameter airway (bronchoscopic implantation) (37). Mayse et 
al. refer that this lung transponder has 100 % long-term fixation rates over 60-day 
period for 54 bronchoscopic implanted transponders in canine lungs (50). In the 
European Union, the Beacons were approved to be used in lung treatments by CE 
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Mark. The first application for lung tumor treatment was already conducted in August 
of this year in the Fundação Champalimaud in Lisbon, Portugal. 
Pancreas 
A study has been developed in The Vanderbilt Clinic, Nashville by University of 
Pennsylvania (2011), with 5 locally advanced pancreatic cancer patients (with no 
metastatic disease). Each patient underwent implantation of three regular Beacons. 
Transponder implantation was well tolerated in all patients, with minimal migration: a 
single transponder migrated in a patient who had intractable vomiting out of the 15 
transponders implanted. To monitor the stability of the transponder placement, 
intertransponder distance was obtained before the start of each fraction using the 
Calypso system.  
Data from 164 treatments was analyzed. Mean intrafractional motion was superior 
7,2 mm; inferior 11,9 mm; anterior 4,9 mm; posterior 2,9 mm; left 2,2 mm; and right 
3,1 mm. All these values were smaller when applied breath holding while treating 
(157 treatments analyzed): superior 4,3 mm;; anterior 2,5 mm; posterior 1,7 mm; 
inferior 8,1 mm; left 1,0 mm; and right 2,1 mm (17). 
 
Electromagnetic Guided Real-Time Dynamic Multileaf Collimator Tracking System 
In the past few years researchers have investigated Dynamic Multileaf Collimator 
tracking possibilities (51-54). The goal of these investigations is to create a system able 
to find the target location and reposition the treatment beam to compensate for target 
motion. Considering this, Calypso System can be the key tool on finding target location. 
To reposition the treatment beam a DMLC is used (55-57). 
There are some obstacles when integrating these systems. Once target movement is 
detected, the data stream is input to the DMLC tracking software, which generates the 
ideal beam aperture. Depending on the MLC, this ideal beam aperture may not be 
viable because of MLC physical limitations such as finite MLC leaf widths or the paired 
leaf structure. Another limitation is related to a finite time lag that is observed between 
motion detection and MLC response – system latency – which is spent in motion 
detection, the calculation of the new leaf positions and the time required by the MLC 
leaves to reach their new positions (55-57).  
To reduce the system latency, studies have been made on predictive algorithms to 
estimate future target positions (57, 58). 
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Wu et al. studied an algorithm capable of readjusting treatment beam for translational 
and also rotational intrafraction movements. They tested this integrated system with 
success. The system detected and adapted the treatment beam for translation and 
rotation movements (55). 
Sawant et al. refer to have built their system successfully. The system was tested on 
patient-derived three dimensional motion trajectories comprising two lung tumors and 
one prostate trace. Tracking accuracy was sub-2mm for the respiratory motion and 
sub-1mm for prostate motion (56). 
 
Discussion 
The Calypso 4D Localization System is a technology based on electromagnetic 
transponders detection which enables precise three-dimensional localization and 
continuous tracking of tumor target. The main advantage of this system with respect to 
other systems continuous internal tracking with no extra ionizing radiation delivered to 
the patient. Advantages and disadvantages should be considered when thinking of 
acquiring this system as well as costs and objectives on how to use the system in the 
clinic. 
 
Quality Assurance 
Balter et al. tested the accuracy of Calypso® system when localizing one and three 
transponders. The accuracy was higher for one transponder detection; still both tests 
resulted in sub-millimeter shift values. It was also performed a similar test in 0,9 % 
saline solution - concentration that simulates a conductivity environment compared to 
twice that of human tissue. The accuracy of the system was lower, but the values were 
also below a millimeter, showing that transponder detection should be accurate in 
human body. For all these tests the accuracy decreased as the beacon(s) distance to 
the array increased, but the measured values kept being sub-millimeter (31).  
Ogunleye et al. evaluated the difference between Calypso and KV planar image for 30 
different phantom positions: values were sub-millimeter. When he repeated the process 
with 259 more fractions the difference between the two systems was higher than 1 mm 
(1,2 mm in the Z direction), so values are not that small. However, OBI system 
uncertainty should be taken in consideration in these tests, added to Calypso® system 
inner uncertainty present in other studies (38). 
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Action Protocol for Treatment Intervention 
Regarding action protocols on how to intervene when using Calypso® system to 
monitor a treatment several examples were presented.  
The pancreatic study with the 3 mm action protocol was performed on patients treated 
with 3D conformal treatment using 4 fields and a 1 to 1,5 cm margin was added to the 
CTV to construct a PTV_4500; there was no reference to the linac used to deliver the 
treatment (17). The prostate study that used this same protocol referred that IMRT 
treatments were analyzed on 44 prostate treatment fractions of 28 patients; there was 
mention neither to PTV margins nor to the linac used to deliver these treatments (40).  
Su et al. referred that each patient underwent 28 treatment sessions, each about 8 
minutes long, but there was also no reference to the treatment plans (PTV margins, 
technique) or to the linac that delivered these treatments (41). 
Shah et al. treated their patients in 40 sessions. The PTV margins were 3 mm posterior 
and 5 mm in all other directions (38). 
There are no studies available on the validity of these protocols. It is however to note 
that the treatments administered in these studies were different from clinic to clinic so it 
is natural that the protocols were also different. More investigation should be performed 
regarding action protocols and the treatments they apply to. A recommendation for a 
future study on action protocols could include suggestions on how calypso margins 
should be defined according to PTV margins, time of irradiation (regular or FFF beams, 
3D conventional or IMRT techniques), and target localization (natural movement of 
target and surrounded OARs). 
 
Clinical applications 
Concerning prostate treatments, Calypso System has been implemented and used in 
several clinics. It detects prostate movements due to breathing movements, peristaltic 
movements and other natural processes. However, depending on the protocol being 
used, it may be necessary to acquire images to assess OARs position related to the 
PTV (such as the rectum and the bladder). 
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Another obstacle for prostate treatment is the transponder implantation maximum 
depth in tissue. Prone position has been presented as an alternative (36, 38, 43). It is 
to refer that previous literature presents studies on the stability of prone versus supine 
positions.  
Several studies indicated that there is more interfraction movement when the patient is 
in prone position (59, 60). Considering that positioning the patient using Calypso® 
system already corrects interfraction motion, it makes sense to analyze intrafraction 
motion in prostate in both positions. 
At Cancer Center of Irvine it was decided to treat prostate in supine position after a 
local study was performed in 15 patients by Wilder et al. (61). The study evaluated 
intrafraction movement in supine and prone position and position preference of the 
patients. The study was performed in patients with gold seeds implanted. 
Anteroposterior and lateral KV planar images were acquired to evaluate intrafraction 
movement. Mean values were 0,6 (δ=0,9), 1,6 (δ=1,8) and 1,7 (δ=1,4) mm in the 
supine position and 1,0 (δ=1,2), 2,2 (δ=2,0) and 2,1 (δ=1,2) in the prone position in the 
X, Y and Z directions, respectively. There was no significant difference in the 
intrafraction prostate motion of the two positions and 80 % of the patients were more 
comfortable in the supine position.  
Kitamura et al. analyzed intrafraction motion using a real-time tumor-tracking system 
that uses two fluoroscopic images acquired 30 times per second and software that is 
able to detect gold markers position. Mean values for ten patients were 0,1 (δ=0,1), 0,3 
(δ=0,2) and 0,3 (δ=0,4) mm in the supine position and 0,5 (δ=0,4), 1,4 (δ=0,5) and 1,6 
(δ=0,4) in the prone position in the X, Y and Z directions, respectively. It was concluded 
that internal organ motion is less frequent in the supine position than in the prone 
position (62). 
The decision on the patient position for prostate treatment lies in each radiotherapy 
department. On one hand supine position is more comfortable for the patient, and 
several studies indicate less inter- and intrafraction motion in this position; on the other 
hand a department that has Calypso® system available may consider that prone 
position is an appropriate alternative to treat large prostate patients so those 
movements can be detected and can be corrected by technicians. 
It is of note that none of this studies compared supine and prone positions rotation 
shifts. More investigation should be performed in this area. 
13 
 
Clinical application of the Calypso System in tumors other than prostate has not been 
approved in USA yet, and CE Mark approval for lung treatments with Anchored 
Beacons in EU is still very recent. Therefore, no published clinical results on this 
application are available yet, but it is understandable the advantage of the use of 
transponders in regions of significant target movement.  
 
Electromagnetic Guided Real-Time Dynamic Multileaf Collimator Tracking System 
In the near future, a few integrated systems have been created and tested in 
phantoms, with success for tracking target position. The integration of Calypso 4D 
Localization System and Dynamic Multileaf Collimator is being developed in order to 
achieve an Electromagnetic Guided Real-Time DMLC Tracking System. Still, these 
algorithms have taken into account only the target position, OARs positions are not 
considered, yet.  
 
Conclusion 
The Calypso 4D Localization System allows real-time localization and monitoring of the 
target, with no ionizing radiation additional administration. It is a very important tool in 
prostate cancer treatment. More studies are currently being developed. 
Further research has to be performed: (1) prostate studies involving a larger cohort of 
patients, (2) clinical application in clinical sites other than the prostate and prostate 
bed, (3) the effect of the system on hypofractionated treatments, (4) studies involving 
rotational movement corrections besides translational movement corrections, and (5) 
investigation and implementation of more advance prediction algorithms for DMLC 
systems. 
Improvements and integrations are also expected in the future, such as (1) phantoms 
dedicated to Calypso and/or DMLC tracking system studies, (2) integration of Calypso 
System with linear accelerator, (3) integration of Calypso System with robotic couch 
(6D), and (4) improvements in software design and speed of processing hardware 
allowing the clinical use of Calypso + DMLC integrated system into achieving adaptive 
radiotherapy.  
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Abstract 
Introduction: The Calypso 4D Localization System gives the possibility to track the 
tumor during treatment, with no additional ionizing radiation delivered. To monitor the 
patient continuously an array is positioned above the patient during the treatment. We 
intend to study, for various gantry angles, the attenuation effect of the array for 6- and 
10 MV and FFF 6- and FFF 10 MV photon beams. 
Materials and methods: Measurements were performed using an ion chamber placed 
in a slab phantom positioned at the linac isocenter for 6 MV, 10 MV, FFF 6 MV and 
FFF 10 MV photon beams. Measurements were performed with and without array 
above the phantom for 0˚, 10˚, 20˚, 40˚ and 50˚ beam angle for a True Beam STx linac, 
for 5 x 5 cm2 and 10 x 10 cm2 field size beams to evaluate the attenuation of the array. 
Results and discussion: Attenuation measured values were up to 3 %. Angular 
dependence of the attenuation was observed. Attenuation values were between 1 % - 
2 % with the exception of the 30o - 50o gantry angles which were up to 3,3 %. 
Conclusion: Attenuation of treatment beam by the Calypso array may be within 
acceptable limits. 
Keywords: Calypso, array, attenuation. 
 
Introduction 
Higher accuracy and reproducibility in radiotherapy has led to great development in 
imaging and monitoring systems. Megavoltage imaging has been used clinically for 
many years, and kV imagers have also been installed in linacs all over the world.  
Monitoring systems for tracking movement during treatment have been used to monitor 
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patient surface – e.g. infrared tracking of external markers or virtual view of the patient 
surface – or the tumor movement – e.g. fluoroscopy (1-11). 
The Calypso 4D Localization System is a monitoring system that gives the possibility to 
track the tumor during treatment, with no additional ionizing radiation delivered, a great 
advantage when compared to other systems available (12). 
This system has five components: Beacon transponders, the console, the array, the 
optical localization subsystem and the monitoring station (13). The array consists of 4 
sources and 32 receiver coils. An oscillating signal (25 Hz) through the source coil 
generates resonance in the transponders. When this signal is turned off, the 
transponders emit electromagnetic signals, which are detected by the receiver coils in 
the array, thereby localizing their positions relative to the array. Meanwhile, the in-room 
infrared camera system tracks the array relative to the isocenter (14). 
To monitor the patient continuously an array is used. This array is positioned above the 
patient during the treatment (13, 15). The internal structure of the array panel contains 
optical targets, source coils and sensors (13). 
Although the array lies between the patient and the beam, it is not included in the dose 
calculation of the treatment planning system. 
Zou et al. studied the array attenuation effect for the regular energies 6 MV and 15 MV 
photon beams for various gantry angles – and concluded that the dose difference due 
to the placement of Calypso array was clinically insignificant to the treatment (16). In 
our institute the calypso system is mainly used in the irradiation of free flattening filter 
(FFF) beams. Given that the removal of the flattening filter lowers the mean energy of 
the beam we propose to study, for various gantry angles, the attenuation effect of the 
array for FFF 6 and FFF 10 MV photon beams. 
 
Materials and methods 
Transmission measurements were performed on a True Beam STx linear accelerator 
(Varian Medical Systems, Palo Alto, CA, USA) using a CC13 ionization chamber of 
0,13 cm3 of sensitive volume (IBA Dosimetry, Germany) connected to a Dose 1 
electrometer (IBA Dosimetry, Germany). Corrections for temperature and pressure 
were applied. 
23 
 
The ionization chamber was inserted in a slab phantom and positioned in the isocenter 
at 5 cm depth. See Figure 1.  
The array was positioned above the phantom in the (0, 0, 0) position indicated by 
Calypso software system, in the same way it is positioned above the patient during 
treatment (See Figure 1). 
 
Figure 1. Gantry angle measurements acquisition scheme 
Measurements were performed for regular 6- and 10 MV and FFF 6- and FFF 10 MV 
energies, for both 5 x 5 and 10 x 10 cm2 square field sizes. The readings were obtained 
in six different gantry angles: 0 ˚, 10˚, 20˚, 30˚, 40˚ and 50˚. For each measurement, 
200 monitor units (MU) were delivered at a dose rate of 600 MU/min for regular beam 
energies and 800 MU/min for FFF energies. 
Measures were performed with and without the array in the beam path. Each 
measurement was repeated five times. The transmission measurements were 
registered in a table. The attenuation was calculated according to the formula:  
attenuation		%  	1 
measurement	with	array
measurement	without	array
 ∗ 100 
The attenuation calculated values were registered and analyzed. Mean and standard 
deviation were calculated. 
A fit was done to the attenuation curves to evaluate the goodness of the fit. 
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Results and discussion 
The attenuation values measured were higher for 5 x 5 cm2 fields than for 10 x 10 cm2 
fields for all energies and for the same measurement conditions. Therefore, the data 
shows that the beam attenuation is field size dependent. This dependency was not 
calculated. Field size dependency has been previously reported in other devices 
attenuation studies, although this dependency was also not quantifiable in those 
reports (17-19). 
These studies usually also report an angular dependence on the attenuation of the 
beam by devices. A second degree polynomial fit was applied to the attenuation 
curves. For the 5 x 5 cm2 field size curves, the r2 value for 6 MV, 10 MV, FFF 6 MV and 
FFF 10 MV of 0,97; 0,95; 0,95 and 0,96, respectively. For 10 x 10 cm2 field size curves, 
the r2 value was 0,96; 0,98; 0,97 and 0,98, for the same energies respectively. 
Therefore, there is a tendency for higher attenuation values as the gantry angle 
increases, as it is shown in Figures 2 and 3.  
 
Figure 2. Attenuation by Calypso array of 5 x 5 cm2 field size beams. 
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Figure 3. Attenuation by Calypso array of 10 x 10 cm2 field size beams. 
 
Only one measurement showed a standard deviation of 0,2 %. All the other points 
measured showed 0,0 % or 0,1% standard deviation. Measurements can be 
considered precise. 
The array attenuation calculated values are comparable to attenuation values 
presented previously. Zou et al. reported that the attenuation on the array was about 2 
% - 3 % for both 6 and 15 MV energies, for 1 x 1 cm2 field size beams at gantry angles 
between 0˚ - 40˚. The calculated attenuation slowly increased above these values for 
angles around 50˚ - 60˚ (16). 
Here the calculated attenuation values were between 1 % - 2 % for gantry angles 0˚, 
10˚, 20˚ and 30˚, for both field sizes for all energy beams. Acquisitions at 40˚ and 50˚ 
gantry angles showed higher attenuation values. The higher attenuation calculated 
value was 3,3% for a 5 x 5 cm2 field for a FFF 6 MV beam (gantry angle: 50˚), and 3,1 
% for a 10 x 10 cm2 field of the same energy beam, at the same gantry angle. 
A limitation of this study is that point measurements were performed and because the 
FFF energy beams are not flat by definition, positioning accuracy of the ionization 
chamber can be challenging. Furthermore, the array is also inhomogeneous, as it 
contains source coils, sensors and infrared targets. A 2D EPID detector could be used 
to assess that, however it has to be compatible with the use of FFF beams.  
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Conclusion 
The behavior of the array attenuation curves is important to study due to its 
inhomogeneous structure. 
Dose attenuations were measured to be within 1 % - 2 % with the exception of the 30o - 
50o gantry angles which were up to 3,3%. The results indicate that the dose attenuation 
of the Calypso array may be within acceptable limits. 
Future work should assess the Calypso attenuation of radiotherapy treatment beams 
with more detail. 
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Abstract 
Introduction: Our clinic acquired a Calypso 4D Localization System where 
electromagnetic (EM) frequencies to detect implanted transponders in the patient are 
used. Carbon fiber is an electrical conductive material which interferes with EM 
frequencies. In order to be able to use the Calypso System the carbon fiber tabletop in 
the treatment room must be replaced. It is our goal to determine the attenuation of the 
new tabletops. 
Materials and Methods: Transmission measurements were performed using an 
ionization chamber inserted in a slab phantom positioned at the isocenter for 6 MV, 10 
MV, 6FFF MV and 10FFF MV photon beams for 0˚, 30˚ and 60˚ beam angles for 5 x 5 
cm2 and 10 x 10 cm2 field size beams. The attenuation was calculated for each 
measurement. 
Results: At 0o incidence on the Exact IGRT Couch, the measured attenuation for 10 x 
10 cm2 was 2,8% and 2,1% for 6 MV and 10 MV beams, respectively. For the same 
field size was measured 3,3% and 2,6% attenuation for 6FFF MV and 10FFF MV 
beams, respectively. At the same incidence and regarding the other tabletops, the 
calculated attenuation is lower. For 10 x 10 cm2 field there is 2,0%, 1,4%, 2,1% and 
2,6% attenuation for 6MV, 10 MV, 6FFF MV and 10FFF MV energy beams on the 
kVueTM Universal Couch. For the KvueTM Calypso ®Couch 10 x 10 cm2 irradiation field, 
the measurements were respectively 1,6%, 1,3%, 1,9% and 1,5%. This tendency is 
observed for all gantry angles. 
Discussion: The attenuation outputs were higher for the Varian Exact IGRT Couch 
when compared to the kVue tabletops. kVueTM Calypso® Varian tabletop showed 
smaller mean attenuation of the beams than kVueTM Universal Tip Insert for all 
measurements. 
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Conclusions: There was no loss in treatment quality administration due to beam 
attenuation in the tabletop when tabletops were exchanged because of Calypso system 
integration. There is no need to change between kVue tabletops whenever there is a 
regular treatment or a Calypso System guided treatment. 
Keywords: Calypso, tabletop attenuation, carbon fiber, kevlar 
 
Introduction 
The main goal in radiotherapy is to deliver the prescribed dose to the target volume 
affecting the surrounding healthy tissues as less as possible (1-5). In order to achieve 
the later, radiation is delivered to the patient from different angles, while the patient is 
lying on the treatment table. When posterior and posterior oblique treatment beams 
pass through the treatment couch attenuation of the photon beams occurs (6). 
Radiotherapy treatment couches are usually made of carbon fiber. Carbon fiber is a 
polymer like component (7), widely used in radiotherapy treatments due to its high 
mechanical strength and rigidity, low specific density, extremely light, and regularly 
considered radiotranslucent (8-11). Moreover, artifacts in the images acquired in 
clinical routine for setup correction are avoided if carbon fiber components are used 
(12, 13). 
The attenuation of various carbon fiber couches has already been reported by other 
authors (10, 14-16). Some treatment planning systems have the possibility to include 
the attenuation factor for the tabletop used for the treatment.  
A system for tracking the tumor has been approved for radiotherapy treatment: Calypso 
4D Localization System. It consists of a magnetic array positioned above the patient 
during treatment that continuously detects the position of the transponders that were 
previously placed inside the patient, in/by the tumor. Three infrared cameras in the 
room detect the position of the array relative to the isocenter (17). 
For the beacons detection to be accurate, it is necessary to guaranty some 
requirements. beacons have to be in the array’s volume detection, there is a maximum 
distance between the treatment isocenter and the beacons, and also, no electric 
conductive materials are allowed in the array’s volume detection. This last item may 
prevent patients with certain metallic prosthesis to be treated with Calypso. 
Besides metal, carbon fiber compatibility with Calypso system is also an issue. It is 
known that carbon fiber is an electrical conductive material and it interferes with EM 
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frequencies detection (7, 12). If the treatment couch has a carbon fiber tabletop, it has 
to be replaced by a Calypso system compatible tabletop. As compared to other light-
weight materials, such as carbon fiber, Kevlar is less conductive and thus tends to 
cause less distortion in the electromagnetic field (7, 18). 
In our institute a Calypso 4D Localization System was acquired. The previous 
treatment couch had to be changed according to Calypso system guidelines when 
calypso was installed. The Varian Exact IGRT Couch (no rails) was replaced by a 
tabletop system with rails support and two different tabletops – kVueTM Universal Tip 
Insert (carbon fiber) and kVueTM Calypso ® Varian Insert (Kevlar). 
In the current article we report on the attenuation effect of the above mentioned three 
tabletops for regular 6- and 10-MV photon beams and also Flattening Filter Free (FFF) 
6- and 10 MV photon beams produced by a Varian True Beam STx machine, for 
various gantry angles. It is our goal to (1) determine the attenuation of the new 
treatment tabletops and (2) to verify if it is adequate not to switch between kVueTM 
Calypso® Varian and kVueTM Universal Tip tabletops according to the use of calypso 
system or not, respectively. 
 
Materials and Methods 
Measurements were performed on a True Beam STx linear accelerator (Varian Medical 
Systems, Palo Alto, CA, USA) equipped with regular 6 MV and 10 MV and also FFF6 
MV and FFF 10 MV energies. 
Three tabletops were studied: Varian Exact IGRT tabletop (carbon fiber), kVueTM 
Universal Tip Insert (carbon fiber) and kVueTM Calypso ® Varian Insert (kevlar). 
Transmission measurements were performed with a CC13 ionization chamber of 0,13 
cm3 of sensitive volume (IBA Dosimetry, Germany) connected to a Dose 1 electrometer 
(IBA Dosimetry, Germany). Corrections for temperature and pressure were applied. 
The ionization chamber was positioned aligned to the isocenter inserted in a slab 
phantom at 5 cm depth. The source-detector distance was 100 cm.  
Measurements were done for the four referred energies, for both 5 x 5 cm2 and 10 x 10 
cm2 square field sizes. The readings were obtained in three different gantry angles: 0o, 
30o and 60o. For every measurement 200 MU were delivered at a dose rate of 600 
MU/min for regular beam energies and 800 MU/min for FFF energies.  
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Each tabletop was positioned on top of the phantom and all measurements were 
repeated for each tabletop - couch rails not considered in this study (see Figure 1). 
Summarizing, 72 points were measured. 
  
Figure 1. The three tabletops studied, in measurement acquisition position: Varian 
Exact IGRT tabletop (left), kVueTM Universal Tip Insert (center), kVueTM Calypso ® 
Varian Insert (right) 
With the Varian Exact IGRT tabletop, the attenuation measurements were performed 
from the medium thickness part of the couch (longitudinal position equivalent to pelvic 
region treatment), as the thickness of the tabletop is not constant in the longitudinal 
direction. 
The transmission measurements were registered in a table. The attenuation was 
calculated according to the formula:  
attenuation		%  	1 
measurement	with	tabletop
measurement	without	tabletop
 ∗ 100 
 
Each measurement point was repeated five times. Mean of the five repetitions was 
calculated and registered. Standard deviation was calculated to evaluate the precision 
of the measurements. 
 
Results 
The attenuation measurements for the each tabletop for the three gantry angles 
measured for the 5 x 5 cm2 field size are presented in Figures 2, 3 and 4. The 
attenuation measurements for the each tabletop for the three gantry angles measured 
for the 10 x 10 cm2 field size are presented in Figures 5, 6 and 7.  
Regarding the 72 points measured only two points has a standard deviation of 0,2 %, 
both in attenuation measurements of 6 MV fields by Varian Exact IGRT Couch: gantry 
angle 0o for 5 x 5 cm2 field size and gantry angle 30o for 10 x 10 cm2 field size. All the 
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other measured points showed 0,0 or 0,1% standard deviation. It can be said that 
measurements have good precision. 
 
 
Figure 2. Mean attenuation by KvueTM Calypso ® Varian Insert for the three gantry 
angles measured for a 5 x 5 cm2 field size. 
 
Figure 3. Mean attenuation by kVueTM Universal Tip Insert for the three gantry angles 
measured for a 5 x 5 cm2 field size. 
 
Figure 4. Mean attenuation by Varian Exact IGRT Couch for the three gantry angles 
measured for a 5 x 5 cm2 field size. 
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Figure 5. Mean attenuation by KvueTM Calypso ® Varian Insert for the three gantry 
angles measured for a 10 x 10 cm2 field size. 
 
Figure 6. Mean attenuation by kVueTM Universal Tip Insert for the three gantry angles 
measured for a 10 x 10 cm2 field size. 
 
Figure 7. Mean attenuation by Varian Exact IGRT Couch for the three gantry angles 
measured for a 10 x 10 cm2 field size. 
 
The output measurements show that the attenuation is field size dependent. The 
attenuation values measured were always higher for 5 x 5 cm2 fields than for 10 x 10 
cm2 fields, in the same measurement conditions. 
The collected data also indicates an angular dependence of the attenuation. As 
expected all measurements (for both field sizes, for all energies, for all tabletops) 
indicate higher attenuation values as the gantry angle increases.  
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At 0o incidence on the Exact IGRT Couch, the measured attenuation for 10 x 10 cm2 
was 3,0% and 2,2% for 6 MV and 10 MV beams, respectively. For the same field size 
was measured 3,4% and 2,6% attenuation for 6FFF MV and 10FFF MV beams, 
respectively. At the same incidence on the other tabletops, the measured attenuation is 
lower. For 10 x 10 cm2 field there is 1,8%, 1,4%, 2,1% and 1,6% attenuation for 6MV, 
10 MV, FFF6 MV and FFF10 MV energy beams on the kVueTM Universal Couch. For 
the KvueTM Calypso ®Couch 10 x 10 cm2 irradiation field, the measurements were 
respectively 1,6%, 1,2%, 1,9% and 1,4%.  
This example shows the tendency observed for all gantry angles, and for all tabletops: 
6MV and FFF6 MV energy beams are more attenuated in the tabletop than the 10 MV 
and FFF10 MV energy beams. Also, FFF energy beams are more attenuated than the 
respective regular energy beam. 
The Figures 8, 9, 10, 11, 12 and 13 show the same data presented before but they 
were rearranged in order to show the attenuation values for the three different 
tabletops, when maintaining the field size and the gantry angle. 
 
Figure 8. Mean attenuation for the three tabletops for 5 x 5 cm2 field - gantry angle 0o. 
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Figure 9. Radiation attenuation for the three tabletops for 5 x 5 cm2 field - gantry angle 
30o. 
 
Figure 10. Mean attenuation for the three tabletops for 5 x 5 cm2 field - gantry angle 
60o. 
 
Figure 11. Mean attenuation for the three tabletops for 10 x 10 cm2 field - gantry angle 
0o. 
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Figure 12. Mean attenuation for the three tabletops for 10 x 10 cm2 field - gantry angle 
30o. 
 
Figure 13. Mean attenuation for the three tabletops for 10 x 10 cm2 field - gantry angle 
60o. 
For all 72 measured points it is clear that the Exact IGRT Couch presents higher 
attenuation values than the other two tabletops. 
Mean attenuation values by kVueTM Universal Couch are higher than mean attenuation 
by KvueTM Calypso ®Couch for all the measured points. Nevertheless the tips of error 
bars of kVueTM Universal and KvueTM Calypso ®Couches are coincidental for gantry 
angles 0o and 30o for 6MV energy beam and for gantry angle 30o for FFF 10 MV 
energy beam (Figures 11 and 12).  
 
Discussion 
Attenuation measurements 
As previously reported (19-21), the measurements showed field size dependence. 
Higher attenuation was measured for the 5 x 5 cm2 field size beams than for 10 x 10 
cm2, for the same measurement conditions. 
Measurements were also angular dependent. The higher the gantry angle, the higher is 
the attenuation. With more oblique angles, the couch distance crossed by the beam is 
longer. This dependence has also been reported already (16, 19, 21). 
Vanetti et al measured the attenuation of the thinner part of the Varian Exact IGRT 
Couchtop for a 10 x 10 cm2 field size with a 6 MV photon beam. The authors report 
attenuations of 2,3% and 3,1% with gantry angles of 0° and 45°, respectively (22). 
Seppälä et al. found the corresponding measured attenuations to be 1,9% and 2,7% 
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(13). Our study reports on the attenuation values for a thicker part of the couch which 
corresponds to the pelvic treatment region. Our results are between 3,0% and 5,3% for 
0° and 60° gantry angles, respectively, which are s ignificant values. All these data 
support angle dependence attenuation. 
6 MV energy beams are more attenuated than 10 MV energy beam for all tabletops 
used in this study.  Li et al. (19) studied the attenuation of two tabletops (Varian Clinac 
standard couch and Varian Exact IGRT couch) in 6MV and 18 MV beams and stated 
that the 6 MV photon beam yielded a larger attenuation difference than the 18 MV 
photon beam. Considering 6 MV beams are less energetic than 10 MV beams, it is 
expected that more photons of this beam are attenuated in the tabletop than 10 MV 
photons are. Similarly, this happens with 6FFF MV and 10FFF MV beams.  
On the other hand, 6FFF MV energy beams are more attenuated than 6 MV beams. 
Regular energy beams go through the flattening filter leading to a more homogeneous 
field. FFF beams contain the low energy photons that were not attenuated by the 
flattening filter. Therefore, it is expected that more photons are attenuated in the 
tabletop.  
 
Tabletops comparison  
For both field sizes and for all energy beams, the attenuation outputs were definitely 
higher for the Varian Exact IGRT Couch when compared to the kVue tabletops. Figure 
10 shows the maximum attenuation measured values for each tabletop (Gantry = 60o 
for 5 x 5 cm2). The original tabletop mean attenuation is 5,8% and 4,4% for 6MV and 
10 MV respectively. Measurements with the new tabletops are 4,7% and 3,5% for the 
carbon fiber tabletop, and 4,2% and 3,2% for the Kevlar Calypso tabletop, respectively. 
FFF energy beams are attenuated for these tabletops the same way. For the same 
field size Varian Exact IGRT Couch mean attenuation of 6FFF MV and 10 FFF MV are 
6,6% and 5,0%, respectively. kVueTM Universal Tip Tabletop corresponding 
measurements are 5,3% and 4,0% and kVueTM Calypso ® Varian tabletop 
corresponding measurements are 4,8% and 3,6%, respectively. All the remaining 
measurements follow the same tendency, as it is shown in Figures 8-13. 
Therefore treatment delivery was not compromised due to beam attenuation in the 
tabletop when couches were changed because of the Calypso System carbon fiber 
limitation. Nevertheless, in the TPS used in the clinic (Eclipse, version11, Varian, Palo 
Alto, USA) there was a loss in treatment quality administration when the tabletop was 
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taken into consideration by TPS. In Eclipse the treatment couch can be modeled to 
account for beam attenuation. Varian Exact IGRT Couch characteristics are available 
in the TPS and were included in every treatment plan. None of the kVue tabletops are 
available for this tool, yet.  
The attenuation measurements for the kVue tabletops were closer to each other. 
kVueTM Calypso® Varian tabletop showed smaller mean attenuation of the beams than 
kVueTM Universal Tip Insert for all energies. As it was previously referred there was a 
coincidence in error bars limit in three measured points. Since 72 points were 
evaluated, it was considered that kVueTM Calypso® Varian tabletop attenuated 
radiation less than kVueTM Universal Tip Insert. Therefore, it was decided that in the 
department there was no need to change between tabletops whenever there was a 
regular treatment or a Calypso System guided treatment.  
 
Limitations of the study 
This study reports on the attenuation of radiotherapy treatment beams by treatment 
tabletops. Four energy treatment beams are analyzed: 6MV, 10MV, 6FFF MV and 
10FFF MV. All measures were performed at the isocenter. 6 MV and 10 MV beams can 
be considered homogeneous, so measurements can be considered representative of 
the whole field. 
Varian Exact IGRT Couch insert is supported on the couch stand, but the two new 
tabletops (kVueTM Universal Tip and kVueTM Calypso ® Varian) are supported on two 
rails that also are in the beam path. Every tabletop measurement was performed with 
the tabletop positioned on the phantom, which means that rail supports were not taken 
into consideration in this study. 
Although several studies have reported on carbon fiber rails support beam attenuation 
(19, 20, 23), none is applicable to the rails with the calypso system because the 
material is Kevlar instead of carbon fiber. 
 
Conclusions 
Attenuation output measurements are field size- and angular- dependent. 
Low regular energy beams are more attenuated than higher regular energy beams. 
FFF energy beams are more attenuated than regular energy beams.  
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The Exact IGRT Couch presents higher attenuation values, followed by kVueTM 
Universal Couch and, finally, the KvueTM Calypso ®Couch. Therefore treatment 
delivery was not compromised by the exchange of tabletops. However, attenuation of 
treatment tabletops should be corrected in the treatment planning.  Unfortunately, kVue 
tabletops are not included in the treatment plan system yet. It is suggested that the 
TPS should have kVue tabletops characteristics available so they can be taken into 
consideration in the treatment plan. 
Future work should include more detailed studies on FFF energy beams attenuation as 
they are not homogeneous. Calypso tabletops rail support system attenuation should 
also be studied in the future. 
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General Conclusion 
The purpose of this study was to understand how Calypso® system works and to 
investigate whether its limitations lead to any considerable loss in radiation treatment 
delivery. 
In conclusion, Calypso® is a wireless system that allows real-time localization and 
monitoring of the target, with no additional administration of ionizing radiation. 
In order for the system to work, an array is placed above the patient during treatment. 
Radiation attenuation of the array was measured. It was shown that the attenuation 
values were to be within 1%-2% for gantry angles 0o-30o. For gantry angles between 
30o-50o those values could be up to 3,3%. These attenuation values may be 
considered within acceptable limits. 
Regarding the tabletop exchange, it was concluded that there was no loss in treatment 
administration due to radiation attenuation by the new tabletops. The original tabletop - 
Exact IGRT Couch - presents higher attenuation values, followed by kVueTM Universal 
Couch (carbon fiber) and, finally, the KvueTM Calypso ®Couch (kevlar). 
